Trials / Withdrawn
WithdrawnNCT02034890
Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection
Is Intra - Neobladder Installations of Hyaluronic Acid, Effective in Reducing Neobladder Orthotropic Reconstruction Post-operative Urinary Tract Infections?
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt to reduce the incidence of urinary tract infections in patients after orthotopic neobladder reconstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronic Acid | intravesical instillation of 40 mg of hyaluronic acid in 6 specific time points: 1,2,3 and 4 weeks postoperatively (After radical cystectomy and orthotopic neobladder reconstruction) 2 and 3 months postoperatively |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-03-01
- First posted
- 2014-01-14
- Last updated
- 2019-04-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02034890. Inclusion in this directory is not an endorsement.